The Supriya Lifescience Ltd prices are delayed, login to your account for live prices
LOGIN
Supriya Lifescience Ltd Share Price
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
As on 22 January 2025 at 18:24 IST
Over 1 Month
-1.02%
Over 6 Months
85.19%
Over 1 Year
136.21%
Over 3 Years
50.76%
Supriya Lifescience Ltd Summary
Close
₹
713.35
Open
₹
706
High
₹
718.95
Low
₹
660.90
Volume
2,27,993
Net Turnover (in ₹)
₹
11,78,43,023.40
52Wk High
₹
835.20
52Wk Low
₹
288.90
52Wk High / Low
288.90
835.20
Supriya Lifescience Ltd Fundamentals
Key Financial Data
Market Cap (in ₹Cr)
₹
5,664.38
EPS (TTM)
19.57
Book Value (BV)
112.56
Div. Yield
0.11
%
P/E (TTM)
35.94
Price/Book Value
6.25
Delivery %
32.85
%
Face Value
2
Key Ratios
PE Ratio
22.42
PB Ratio
3.27
EV to Sales
4.56
PEG Ratio
0.69
ROA
14.50
ROE
15.73
Debt-Equity
0.02
Net Profit Margin
18.41
Operating Profit Margin
28.85
Supriya Lifescience Ltd Financials
Profit and Loss
No data available
Balance Sheet
No data available
Cash Flow
No data available
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 581 | 470.43 | 537.63 | 396.22 | 322.71 |
| Total Expenses | 415.31 | 346.94 | 330.38 | 228.91 | 226.52 |
| Profit Before Tax | 165.69 | 123.49 | 207.25 | 167.31 | 96.20 |
| Profit After Tax | 119.11 | 89.86 | 151.81 | 123.59 | 73.35 |
| Operating Profit after Depreciation | 167.80 | 126.57 | 211.44 | 171.39 | 103.05 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 310.13 | 261.54 | 189.77 | 100.04 | 98.57 |
| Total Non Current Assets | 523.43 | 355.39 | 237.22 | 180 | 140.55 |
| Total Current Assets | 397.81 | 464.89 | 497.54 | 265.46 | 195.60 |
| TOTAL ASSETS | 921.24 | 820.28 | 734.76 | 445.47 | 336.15 |
| Total Shareholder's Fund | 815.37 | 699.46 | 615.69 | 268.58 | 149.07 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | 113.31 | 63.61 | 48.80 | 75.89 | 116.67 |
| Net Cash used in Investing Activities | -173.58 | -123.65 | -59.82 | -46.80 | -25.14 |
| Net Cash used in Financing Activities | -22.36 | -10.28 | 149.65 | -14.52 | -29.23 |
No data available
| Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
|---|---|---|---|---|---|
| Total Revenue | 166.10 | 160.63 | 158.18 | 140.07 | 140.10 |
| Total Expenses | 101.39 | 98.08 | 102.68 | 98.59 | 108.34 |
| Profit Before Tax | 62.06 | 59.77 | 53.18 | 40.10 | 29.79 |
| Profit After Tax | 46.15 | 44.64 | 36.93 | 29.79 | 23.88 |
| Operating Profit after Depreciation | 67.23 | 64.77 | 57.69 | 44.55 | 34.23 |
Supriya Lifescience Ltd Technicals
Support and Resistance
S3
S2
S1
Pivot
R1
R2
R3
S1
689.97
S2
676.13
S3
651.62
Pivot
714.48
R1
728.32
R2
752.83
R3
766.67
Moving Average
20 SMA
711
50 SMA
726.11
100 SMA
657.16
200 SMA
531.42
Supriya Lifescience Ltd Corporate Actions
Supriya Lifescience Ltd
₹0.8/Share
Announcement Date
20 Sep 2024
Record Date
21 Sep 2024
Div Yield
40%
Supriya Lifescience Ltd Peer Comparison
| Company | Price | Market Cap (in ₹ Cr) |
|---|---|---|
| Supriya Lifescience Ltd | ₹703.25 | ₹5,659.95 |
| Sun Pharmaceuticals Industries Ltd | ₹1,761.80 | ₹4,22,714.84 |
| Divis Laboratories Ltd | ₹5,818.40 | ₹1,54,460.24 |
| Cipla Ltd | ₹1,427.30 | ₹1,15,270.75 |
| Dr Reddys Laboratories Ltd | ₹1,288.45 | ₹1,07,511.36 |
| Torrent Pharmaceuticals Ltd | ₹3,157.60 | ₹1,06,862.73 |
Supriya Lifescience Ltd News
Supriya Lifesciences declare Quarterly Result
On 24 January 2025
17 Jan 2025, 11:05 am
Supriya Lifescience inaugurates new API production block at Lote Parshuram site
17 Dec 2024, 04:57 pm
Supriya Life gains after bagging approval from ANVISA for Esketamine Hydrochloride
Supriya Lifesciences advanced 1.16% to Rs 783.10 after the company received approval from Brazil's health authority, ANVISA (Ag'ncia Nacional de Vigil'ncia Sanit'ria), for Esketamine Hydrochloride.
09 Dec 2024, 03:58 pm
Supriya Lifesciences to announce Quarterly Result
On 28 October 2024
21 Oct 2024, 03:38 pm
Supriya Lifesciences to hold AGM
On 27 September 2024
14 Sep 2024, 05:22 pm
Supriya Lifescience Ltd Stock Analysis
- Annual revenue for Supriya Lifescience Ltd increased by 23.51% to ₹581 crore in FY 2024 from ₹470.43 crore in FY 2023.
- Annual Net Profit for Supriya Lifescience Ltd increased by 32.56% to ₹119.11 crore in FY 2024 from ₹89.86 crore in FY 2023.
- Promoter Shareholding in Supriya Lifescience Ltd remains unchanged by 0.00% in the most recent quarter, from 68.30% in September 2024 to 68.30% in December 2024.
- Supriya Lifescience Ltd delivered a 1-year return of 136.21% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
- Supriya Lifescience Ltd share price moved up by 1.36% from its previous close of INR ₹703.80. The latest Supriya Lifescience Ltd share price is INR ₹713.35.
- Supriya Lifescience Ltd share price today has been at a low of 660.90 and a high of 718.95. Over the past 52 weeks, the Supriya Lifescience Ltd share price has seen a low of 288.90 and a high of 835.20.
FAQ’s
What is the share price of Supriya Lifescience Ltd today?
Supriya Lifescience Ltd share price as on 22 Jan 2025 is ₹
713.35
What is the Market Cap of Supriya Lifescience Ltd?
The market cap of Supriya Lifescience Ltd stock is ₹5,664.38 Cr.
What is the PE Ratio of Supriya Lifescience Ltd?
The Price to Earnings (P/E) Ratio of Supriya Lifescience Ltd is 22.42
What is the PB Ratio of Supriya Lifescience Ltd?
The Price to Book (P/B) Ratio of Supriya Lifescience Ltd is 3.27
What is the 52 week high of Supriya Lifescience Ltd Share Price?
The 52 week high of Supriya Lifescience Ltd share price stands at ₹835.20
What is the 52 week low of Supriya Lifescience Ltd Share Price?
The 52 week low of Supriya Lifescience Ltd share price stands at ₹288.90
Open Free
Demat Account!
Enjoy ₹11 Brokerage on Stocks Delivery
Equity, F&O and
DP Charges
